Top execs from AstraZeneca, Roche, Sanofi and GSK tout China investments at import expo

Soriot is among several top pharma execs who've renewed their commitment to China at the 2nd China International Import Expo, a top-priority project by the Chinese government to tout its openness to foreign ventures.

Roche sent its vice chairman, André Hoffmann, who hails from the company’s founding family. At the event, the Swiss drugmaker is showcasing its PD-L1 blockbuster Tecentriq, HER2 breast cancer antibody-drug conjugate Kadcyla and new flu drug Xofluza, all of which have not yet been approved in China.